Progyny Inc (PGNY)
Official siteHEALTHCARE • HEALTHCARE PLANS • NASDAQ
Market Cap: $2.74B
Last updated: Nov 17, 2026 at 4:30 PM ET
Progyny Inc (PGNY) Stock Chart
Progyny (PGNY) has a latest price of $36.71 on Nov 17, 2026, 1.3% below its 52-week high of $37.20. Its price rose 49.5% over the past 12 months. The month-end price fell 52.5% over the 5 years through Oct 2026, a compound annual decline of 13.8%.
Price Chart
From Oct 2019 to Oct 2026, its highest month-end close was $64.04 in May 2021 and its lowest $15.05 in Oct 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PGNY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PGNY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 43.8%, and over 6 months it rose 49.2%. The month-end price fell 5.4% over the 3 years through Oct 2026, a compound annual decline of 1.8%.
| Period | Change |
|---|---|
| 1 month | +31.9% |
| 3 months | +43.8% |
| 6 months | +49.2% |
| 12 months | +49.5% |
| 12 months, with dividends | +49.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -5.4% | -1.8% |
| 5 years | -52.5% | -13.8% |
Price by Year
Its best calendar year was 2020, when the price rose 54.4%, and its weakest was 2024, when it fell 53.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $29.19 | +13.7% |
| 2025 | $25.68 | +48.9% |
| 2024 | $17.25 | -53.6% |
| 2023 | $37.18 | +19.4% |
| 2022 | $31.15 | -38.1% |
| 2021 | $50.35 | +18.8% |
| 2020 | $42.39 | +54.4% |
Trading Range
The price is 27.0% above its 50-day average of $28.90 and 47.1% above its 200-day average of $24.95.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $36.71 | |
| 52-week high | $37.20 | -1.3% |
| 52-week low | $16.10 | +128.0% |
| 50-day average | $28.90 | +27.0% |
| 200-day average | $24.95 | +47.1% |
Price Risk
Over 3 years, its largest fall from a peak was 67.2%.
| Measure | Value |
|---|---|
| 1-year beta | -0.09 |
| Largest fall, 1 year | -42.6% |
| Largest fall, 3 years | -67.2% |
Valuation
Progyny traded at 20.4x earnings at the end of 2025, against a 5-year median of 35.5x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PGNY
What is PGNY's 1-year price change?
Progyny's price rose 49.5% over the past 12 months. With dividends included, the 12-month total return was 49.5%.
What is PGNY's 5-year price change?
Progyny's month-end price fell 52.5% over the 5 years through Oct 2026, a compound annual decline of 13.8%. These figures leave out dividends.
What is PGNY's 52-week high and low?
Progyny's 52-week high is $37.20 and its 52-week low is $16.10. Its latest price of $36.71 on Nov 17, 2026 is 1.3% below the high.
What is PGNY's beta?
Progyny's 1-year beta against the S&P 500 is -0.09, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 42.6%.
Is the PGNY chart free?
Yes. Advanced Charting for PGNY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PGNY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors